Amgen Price to Sales Ratio 2010-2024 | AMGN

Historical PS ratio values for Amgen (AMGN) over the last 10 years. The current P/S ratio for Amgen as of December 12, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Amgen P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-12-11 273.41 4.53
2024-09-30 319.63 $60.32 5.30
2024-06-30 307.79 $57.46 5.36
2024-03-31 278.09 $54.97 5.06
2023-12-31 279.54 $52.42 5.33
2023-09-30 258.80 $49.83 5.19
2023-06-30 212.08 $49.36 4.30
2023-03-31 228.76 $48.63 4.70
2022-12-31 246.35 $48.61 5.07
2022-09-30 209.98 $47.91 4.38
2022-06-30 224.92 $47.31 4.75
2022-03-31 221.78 $46.36 4.78
2021-12-31 204.56 $45.20 4.53
2021-09-30 191.73 $44.50 4.31
2021-06-30 218.11 $43.64 5.00
2021-03-31 221.09 $42.79 5.17
2020-12-31 202.79 $43.00 4.72
2020-09-30 222.67 $41.94 5.31
2020-06-30 205.26 $40.56 5.06
2020-03-31 175.26 $39.70 4.41
2019-12-31 206.92 $38.21 5.42
2019-09-30 165.01 $37.40 4.41
2019-06-30 157.14 $36.97 4.25
2019-03-31 160.63 $36.52 4.40
2018-12-31 163.32 $35.46 4.61
2018-09-30 172.73 $33.98 5.08
2018-06-30 152.78 $32.76 4.66
2018-03-31 140.04 $31.45 4.45
2017-12-31 141.81 $31.02 4.57
2017-09-30 151.02 $31.03 4.87
2017-06-30 138.57 $30.87 4.49
2017-03-31 131.06 $30.53 4.29
2016-12-31 116.00 $30.38 3.82
2016-09-30 131.45 $29.96 4.39
2016-06-30 119.21 $29.23 4.08
2015-12-31 125.47 $28.25 4.44
2015-09-30 106.25 $27.94 3.80
2015-06-30 117.49 $27.72 4.24
2015-03-31 121.73 $27.26 4.47
2014-12-31 120.68 $27.47 4.39
2016-03-31 116.71 $26.43 4.42
2014-09-30 106.02 $25.71 4.12
2014-06-30 88.91 $25.38 3.50
2014-03-31 92.14 $24.76 3.72
2013-12-31 84.80 $24.42 3.47
2013-09-30 82.85 $23.49 3.53
2013-06-30 72.71 $22.80 3.19
2013-03-31 75.22 $22.38 3.36
2012-12-31 62.90 $21.90 2.87
2012-09-30 61.25 $20.64 2.97
2012-06-30 52.75 $19.43 2.71
2012-03-31 48.93 $17.97 2.72
2011-12-31 45.98 $16.84 2.73
2011-09-30 39.16 $16.47 2.38
2011-06-30 41.35 $16.12 2.57
2011-03-31 37.88 $15.83 2.39
2010-12-31 38.91 $15.53 2.51
2010-09-30 39.06 $15.28 2.56
2010-06-30 37.28 $15.04 2.48
2010-03-31 42.41 $14.75 2.88
2009-12-31 40.09 $14.30 2.80
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $146.967B $28.190B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
Vertex Pharmaceuticals (VRTX) United States $120.598B 0.00
Gilead Sciences (GILD) United States $115.130B 20.85
Bristol Myers Squibb (BMY) United States $114.896B 48.42
CSL (CSLLY) Australia $86.615B 0.00
Regeneron Pharmaceuticals (REGN) United States $84.945B 19.33
GSK (GSK) United Kingdom $71.399B 8.26
Argenex SE (ARGX) Netherlands $36.575B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.781B 0.00
BioNTech SE (BNTX) Germany $28.370B 0.00
Illumina (ILMN) United States $23.416B 85.34
Biogen (BIIB) United States $22.945B 9.85
BeiGene (BGNE) Cayman Islands $17.965B 0.00
Moderna (MRNA) United States $16.493B 0.00
Genmab (GMAB) Denmark $14.261B 20.92
Incyte (INCY) United States $13.965B 0.00
Insmed (INSM) United States $13.275B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.573B 29.19
Bio-Techne Corp (TECH) United States $12.204B 47.12
Sarepta Therapeutics (SRPT) United States $11.977B 108.10
Exact Sciences (EXAS) United States $11.689B 0.00
Vaxcyte (PCVX) United States $11.348B 0.00
QIAGEN (QGEN) Netherlands $10.534B 21.67
Exelixis (EXEL) United States $10.115B 23.00
Bio-Rad Laboratories (BIO.B) United States $9.437B 32.07
Intra-Cellular Therapies (ITCI) United States $8.893B 0.00
Roivant Sciences (ROIV) United Kingdom $8.815B 0.00
Repligen (RGEN) United States $8.698B 113.32
Ascendis Pharma (ASND) Denmark $8.143B 0.00
Revolution Medicines (RVMD) United States $7.810B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.298B 7.14
Nuvalent (NUVL) United States $6.651B 0.00
Legend Biotech (LEGN) United States $6.546B 0.00
Halozyme Therapeutics (HALO) United States $6.029B 13.62
Blueprint Medicines (BPMC) United States $6.001B 0.00
Cytokinetics (CYTK) United States $5.983B 0.00
Viking Therapeutics (VKTX) United States $5.484B 0.00
Krystal Biotech (KRYS) United States $5.382B 89.11
Telix Pharmaceuticals (TLX) Australia $5.279B 0.00
Alkermes (ALKS) Ireland $5.006B 16.82
TG Therapeutics (TGTX) United States $4.927B 0.00
Axsome Therapeutics (AXSM) United States $4.737B 0.00
Arcellx (ACLX) United States $4.703B 0.00
ADMA Biologics Inc (ADMA) United States $4.640B 49.08
Ultragenyx Pharmaceutical (RARE) United States $4.512B 0.00
Guardant Health (GH) United States $4.406B 0.00
Biohaven (BHVN) United States $4.327B 0.00
Avidity Biosciences (RNA) United States $4.245B 0.00
Immunovant (IMVT) United States $4.241B 0.00
Apellis Pharmaceuticals (APLS) United States $4.229B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.078B 0.00
Scholar Rock Holding (SRRK) United States $3.949B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.512B 0.00
Denali Therapeutics (DNLI) United States $3.435B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.421B 0.00
NovoCure (NVCR) Jersey $3.368B 0.00
Janux Therapeutics (JANX) United States $3.330B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.276B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.246B 0.00
Amicus Therapeutics (FOLD) United States $3.036B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.998B 23.10
Merus (MRUS) Netherlands $2.957B 0.00
SpringWorks Therapeutics (SWTX) United States $2.957B 0.00
Zai Lab (ZLAB) China $2.950B 0.00
Vera Therapeutics (VERA) United States $2.942B 0.00
Kymera Therapeutics (KYMR) United States $2.915B 0.00
Twist Bioscience (TWST) United States $2.900B 0.00
Vericel (VCEL) United States $2.859B 965.33
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.838B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.828B 0.00
Edgewise Therapeutics (EWTX) United States $2.822B 0.00
Keros Therapeutics (KROS) United States $2.781B 0.00
Iovance Biotherapeutics (IOVA) United States $2.615B 0.00
Agios Pharmaceuticals (AGIO) United States $2.473B 0.00
Protagonist Therapeutics (PTGX) United States $2.444B 15.41
Geron (GERN) United States $2.406B 0.00
Beam Therapeutics (BEAM) United States $2.393B 0.00
WAVE Life Sciences (WVE) Singapore $2.350B 0.00
IDEAYA Biosciences (IDYA) United States $2.350B 0.00
NeoGenomics (NEO) United States $2.332B 0.00
Ligand Pharmaceuticals (LGND) United States $2.274B 56.77
Bavarian Nordic (BVNRY) Denmark $2.203B 13.50
Apogee Therapeutics (APGE) United States $2.196B 0.00
ImmunityBio (IBRX) United States $2.195B 0.00
CG Oncology (CGON) United States $2.146B 0.00
Akero Therapeutics (AKRO) United States $2.118B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.093B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.993B 0.00
Belite Bio (BLTE) United States $1.964B 0.00
Disc Medicine (IRON) United States $1.962B 0.00
Structure Therapeutics (GPCR) United States $1.961B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.842B 15.30
Certara (CERT) United States $1.830B 51.68
MannKind (MNKD) United States $1.823B 47.21
Galapagos (GLPG) Belgium $1.799B 0.00
Celldex Therapeutics (CLDX) United States $1.792B 0.00
Fortrea Holdings (FTRE) United States $1.745B 55.57
Neumora Therapeutics (NMRA) United States $1.700B 0.00
Dynavax Technologies (DVAX) United States $1.697B 99.31
Arcus Biosciences (RCUS) United States $1.644B 0.00
Arvinas (ARVN) United States $1.549B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.540B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.534B 0.00
Nurix Therapeutics (NRIX) United States $1.510B 0.00
Viridian Therapeutics (VRDN) United States $1.503B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.495B 0.00
Travere Therapeutics (TVTX) United States $1.458B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.456B 0.00
Intellia Therapeutics (NTLA) United States $1.436B 0.00
Novavax (NVAX) United States $1.413B 0.00
Praxis Precision Medicines (PRAX) United States $1.400B 0.00
MiMedx (MDXG) United States $1.390B 36.38
Spyre Therapeutics (SYRE) United States $1.360B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.327B 0.00
Myriad Genetics (MYGN) United States $1.321B 0.00
ANI Pharmaceuticals (ANIP) United States $1.244B 16.95
Rocket Pharmaceuticals (RCKT) United States $1.219B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.215B 0.00
Mesoblast (MESO) Australia $1.191B 0.00
Upstream Bio (UPB) United States $1.153B 0.00
Septerna (SEPN) United States $1.094B 0.00
Bicara Therapeutics (BCAX) United States $1.084B 0.00
Vir Biotechnology (VIR) United States $1.077B 0.00
Cogent Biosciences (COGT) United States $1.024B 0.00
Adaptive Biotechnologies (ADPT) United States $0.942B 0.00
Pacira BioSciences (PCRX) United States $0.939B 8.84
Gyre Therapeutics (GYRE) United States $0.937B 0.00
Poseida Therapeutics (PSTX) United States $0.930B 0.00
ArriVent BioPharma (AVBP) United States $0.927B 0.00
Liquidia Technologies (LQDA) United States $0.926B 0.00
LENZ Therapeutics (LENZ) United States $0.908B 0.00
Zymeworks (ZYME) United States $0.902B 0.00
Nuvation Bio (NUVB) United States $0.902B 0.00
Immatics (IMTX) Germany $0.898B 0.00
Immunome (IMNM) United States $0.876B 0.00
Replimune (REPL) United States $0.865B 0.00
Pliant Therapeutics (PLRX) United States $0.864B 0.00
AbCellera Biologics (ABCL) Canada $0.860B 0.00
89BIO (ETNB) United States $0.853B 0.00
Cytek Biosciences (CTKB) United States $0.845B 0.00
Castle Biosciences (CSTL) United States $0.826B 147.40
Kura Oncology (KURA) United States $0.793B 0.00
Tyra Biosciences (TYRA) United States $0.791B 0.00
Erasca (ERAS) United States $0.786B 0.00
Avid Bioservices (CDMO) United States $0.782B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.772B 0.00
UniQure (QURE) Netherlands $0.763B 0.00
Prothena (PRTA) Ireland $0.761B 0.00
MBX Biosciences (MBX) United States $0.760B 0.00
CARGO Therapeutics (CRGX) United States $0.755B 0.00
Entrada Therapeutics (TRDA) United States $0.745B 12.52
Rapport Therapeutics (RAPP) United States $0.741B 0.00
Dianthus Therapeutics (DNTH) United States $0.740B 0.00
CureVac (CVAC) Germany $0.731B 5.94
Cullinan Therapeutics (CGEM) United States $0.729B 0.00
Tectonic Therapeutic (TECX) United States $0.719B 0.00
Anavex Life Sciences (AVXL) United States $0.694B 0.00
Arbutus Biopharma (ABUS) United States $0.690B 0.00
Stoke Therapeutics (STOK) United States $0.688B 0.00
GRAIL (GRAL) United States $0.687B 0.00
Oculis Holding AG (OCS) Switzerland $0.668B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Mineralys Therapeutics (MLYS) United States $0.645B 0.00
Oric Pharmaceuticals (ORIC) United States $0.632B 0.00
Pharming Group (PHAR) Netherlands $0.629B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.615B 0.00
Cartesian Therapeutics (RNAC) United States $0.605B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.597B 0.00
Astria Therapeutics (ATXS) United States $0.593B 0.00
CorMedix Inc (CRMD) United States $0.578B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.574B 0.00
Terns Pharmaceuticals (TERN) United States $0.569B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.563B 0.00
IGM Biosciences (IGMS) United States $0.550B 0.00
Humacyte (HUMA) United States $0.537B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.536B 0.00
Third Harmonic Bio (THRD) United States $0.533B 0.00
PureTech Health (PRTC) United States $0.528B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.523B 0.00
Sana Biotechnology (SANA) United States $0.522B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.521B 0.00
Annexon (ANNX) United States $0.520B 0.00
Absci (ABSI) United States $0.503B 0.00
Abivax SA (ABVX) France $0.503B 0.00
ChromaDex (CDXC) United States $0.493B 645.00
Arcturus Therapeutics Holdings (ARCT) United States $0.486B 0.00
Olema Pharmaceuticals (OLMA) United States $0.482B 0.00
MeiraGTx Holdings (MGTX) United States $0.481B 0.00
Celcuity (CELC) United States $0.477B 0.00
Codexis (CDXS) United States $0.473B 0.00
AnaptysBio (ANAB) United States $0.472B 0.00
Kodiak Sciences (KOD) United States $0.470B 0.00
MaxCyte (MXCT) United States $0.468B 0.00
Emergent Biosolutions (EBS) United States $0.464B 0.00
REGENXBIO (RGNX) United States $0.461B 0.00
Allogene Therapeutics (ALLO) United States $0.449B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.448B 0.00
GH Research (GHRS) Ireland $0.447B 0.00
Aura Biosciences (AURA) United States $0.433B 0.00
Prime Medicine (PRME) United States $0.414B 0.00
Alpha Teknova (TKNO) United States $0.414B 0.00
Sangamo Therapeutics (SGMO) United States $0.405B 0.00
Alumis (ALMS) United States $0.401B 0.00
Design Therapeutics (DSGN) United States $0.391B 0.00
Zenas BioPharma (ZBIO) United States $0.383B 0.00
Contineum Therapeutics (CTNM) United States $0.367B 0.00
Northwest Biotherapeutics (NWBO) United States $0.366B 0.00
Sage Therapeutics (SAGE) United States $0.360B 0.00
Kamada (KMDA) Israel $0.349B 21.68
Voyager Therapeutics (VYGR) United States $0.346B 8.93
XOMA Royalty (XOMA) United States $0.346B 0.00
Neurogene (NGNE) United States $0.345B 0.00
Foghorn Therapeutics (FHTX) United States $0.344B 0.00
Prima BioMed (IMMP) Australia $0.343B 0.00
ACELYRIN, INC (SLRN) United States $0.342B 0.00
Jasper Therapeutics (JSPR) United States $0.337B 0.00
Tango Therapeutics (TNGX) United States $0.333B 0.00
C4 Therapeutics (CCCC) United States $0.332B 0.00
EnGene Holdings (ENGN) Canada $0.332B 0.00
Mersana Therapeutics (MRSN) United States $0.331B 0.00
Revance Therapeutics (RVNC) United States $0.319B 0.00
Eton Pharmaceuticals (ETON) United States $0.313B 0.00
AC Immune (ACIU) Switzerland $0.309B 0.00
Benitec Biopharma (BNTC) United States $0.304B 0.00
ITeos Therapeutics (ITOS) United States $0.303B 0.00
Renovaro (RENB) United States $0.302B 0.00
Tenaya Therapeutics (TNYA) United States $0.290B 0.00
Rezolute (RZLT) United States $0.286B 0.00
Lifecore Biomedical (LFCR) United States $0.286B 0.00
Artiva Biotherapeutics (ARTV) United States $0.283B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.278B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.276B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.272B 0.00
Urogen Pharma (URGN) United States $0.268B 0.00
Chimerix (CMRX) United States $0.268B 0.00
ATyr Pharma (ATYR) United States $0.266B 0.00
Anika Therapeutics (ANIK) United States $0.262B 0.00
Abeona Therapeutics (ABEO) United States $0.261B 0.00
Nautilus Biotechnology (NAUT) United States $0.261B 0.00
Ocugen (OCGN) United States $0.253B 0.00
BioStem Technologies (BSEM) $0.252B 22.28
Candel Therapeutics (CADL) United States $0.252B 0.00
Atea Pharmaceuticals (AVIR) United States $0.250B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.249B 0.00
Fate Therapeutics (FATE) United States $0.248B 0.00
TuHURA Biosciences (HURA) United States $0.247B 0.00
DiaMedica Therapeutics (DMAC) United States $0.232B 0.00
Fulcrum Therapeutics (FULC) United States $0.230B 0.00
Compass Therapeutics (CMPX) United States $0.230B 0.00
Biomea Fusion (BMEA) United States $0.223B 0.00
Molecular Partners AG (MOLN) Switzerland $0.222B 0.00
Precigen (PGEN) United States $0.220B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.219B 0.00
Inhibrx Biosciences (INBX) United States $0.219B 0.00
Verastem (VSTM) United States $0.219B 0.00
XBiotech (XBIT) United States $0.216B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.215B 0.00
Climb Bio (CLYM) United States $0.208B 0.00
Alector (ALEC) United States $0.208B 0.00
Opthea (OPT) Australia $0.204B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.203B 0.00
Kyverna Therapeutics (KYTX) United States $0.202B 0.00
Sutro Biopharma (STRO) United States $0.202B 0.00
Solid Biosciences (SLDB) United States $0.200B 0.00
Checkpoint Therapeutics (CKPT) United States $0.194B 0.00
Amarin (AMRN) Ireland $0.193B 0.00
2seventy Bio (TSVT) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
Trevi Therapeutics (TRVI) United States $0.191B 0.00
Inozyme Pharma (INZY) United States $0.190B 0.00
Coherus BioSciences (CHRS) United States $0.190B 0.00
Cardiff Oncology (CRDF) United States $0.189B 0.00
Ventyx Biosciences (VTYX) United States $0.185B 0.00
Caribou Biosciences (CRBU) United States $0.183B 0.00
Semper Paratus Acquisition (TVGN) United States $0.179B 0.00
Nkarta (NKTX) United States $0.178B 0.00
Greenwich LifeSciences (GLSI) United States $0.175B 0.00
BioAge Labs (BIOA) United States $0.172B 0.00
CAMP4 Therapeutics (CAMP) United States $0.171B 0.00
PepGen (PEPG) United States $0.171B 0.00
ScPharmaceuticals (SCPH) United States $0.170B 0.00
Adherex Technologies (FENC) United States $0.169B 0.00
Bright Minds Biosciences (DRUG) United States $0.167B 0.00
TScan Therapeutics (TCRX) United States $0.164B 0.00
Editas Medicine (EDIT) United States $0.164B 0.00
Zura Bio (ZURA) United States $0.164B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.162B 0.00
Gossamer Bio (GOSS) United States $0.161B 0.00
Actuate Therapeutics (ACTU) United States $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.154B 0.00
Seres Therapeutics (MCRB) United States $0.154B 0.00
Repare Therapeutics (RPTX) Canada $0.153B 0.00
Instil Bio (TIL) United States $0.151B 0.00
Cabaletta Bio (CABA) United States $0.150B 0.00
Seer (SEER) United States $0.149B 0.00
InflaRx (IFRX) Germany $0.148B 0.00
Sagimet Biosciences (SGMT) United States $0.144B 0.00
Puma Biotechnology (PBYI) United States $0.144B 6.12
Applied Therapeutics (APLT) United States $0.144B 0.00
Compugen (CGEN) Israel $0.143B 80.00
Black Diamond Therapeutics (BDTX) United States $0.143B 0.00
Elutia (ELUT) United States $0.139B 0.00
Innate Pharma S.A (IPHA) France $0.137B 0.00
Inventiva S.A (IVA) France $0.133B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.131B 0.00
X4 Pharmaceuticals (XFOR) United States $0.130B 0.00
Monopar Therapeutics (MNPR) United States $0.128B 0.00
Leap Therapeutics (LPTX) United States $0.126B 0.00
Akoya Biosciences (AKYA) United States $0.126B 0.00
Aligos Therapeutics (ALGS) United States $0.124B 0.00
Adverum Biotechnologies (ADVM) United States $0.123B 0.00
TELA Bio (TELA) United States $0.117B 0.00
INmune Bio (INMB) United States $0.116B 0.00
Scilex Holding (SCLX) United States $0.113B 0.00
Skye Bioscience (SKYE) United States $0.110B 0.00
Immunic (IMUX) United States $0.109B 0.00
Rani Therapeutics Holdings (RANI) United States $0.107B 0.00
MediciNova (MNOV) United States $0.106B 0.00
Cellectis S.A (CLLS) France $0.106B 0.00
Inovio Pharmaceuticals (INO) United States $0.105B 0.00
Alto Neuroscience (ANRO) United States $0.105B 0.00
Coya Therapeutics (COYA) United States $0.104B 0.00
BioHarvest Sciences (BHST) Canada $0.102B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.100B 0.00
HilleVax (HLVX) United States $0.099B 0.00
Invizyne Technologies (IZTC) United States $0.099B 0.00
23andMe Holding (ME) United States $0.095B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.094B 0.00
Adagene (ADAG) China $0.094B 0.00
Allakos (ALLK) United States $0.093B 0.00
CytomX Therapeutics (CTMX) United States $0.092B 6.94
Nuvectis Pharma (NVCT) United States $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Vigil Neuroscience (VIGL) United States $0.090B 0.00
Genelux (GNLX) United States $0.089B 0.00
I-Mab (IMAB) China $0.086B 0.00
Generation Bio (GBIO) United States $0.085B 0.00
Adicet Bio (ACET) United States $0.084B 0.00
Werewolf Therapeutics (HOWL) United States $0.082B 0.00
Annovis Bio (ANVS) United States $0.082B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Abpro Holdings (ABP) United States $0.081B 0.00
Entera Bio (ENTX) Israel $0.080B 0.00
ALX Oncology Holdings (ALXO) United States $0.080B 0.00
FibroBiologics (FBLG) United States $0.079B 0.00
Adlai Nortye (ANL) Cayman Islands $0.079B 0.00
PDS Biotechnology (PDSB) United States $0.078B 0.00
Ovid Therapeutics (OVID) United States $0.077B 0.00
Agenus (AGEN) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Bluebird Bio (BLUE) United States $0.076B 0.00
Boundless Bio (BOLD) United States $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.075B 0.00
BioAtla (BCAB) United States $0.074B 0.00
Q32 Bio (QTTB) United States $0.072B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.071B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
Invivyd (IVVD) United States $0.070B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
Connect Biopharma Holdings (CNTB) United States $0.068B 0.00
Atara Biotherapeutics (ATRA) United States $0.068B 0.00
DBV Technologies S.A (DBVT) France $0.068B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Vor Biopharma (VOR) $0.067B 0.00
Theratechnologies (THTX) Canada $0.067B 0.00
Immuneering (IMRX) United States $0.066B 0.00
Oncolytics Biotech (ONCY) Canada $0.066B 0.00
Immix Biopharma (IMMX) United States $0.064B 0.00
Shattuck Labs (STTK) United States $0.063B 0.00
Galena Biopharma (SLS) United States $0.063B 0.00
Spero Therapeutics (SPRO) United States $0.063B 16.43
Kronos Bio (KRON) United States $0.062B 0.00
BGM Group (BGM) China $0.062B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.061B 0.00
BeyondSpring (BYSI) United States $0.061B 0.00
Aadi Bioscience (AADI) United States $0.060B 0.00
Elicio Therapeutics (ELTX) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
IO Biotech (IOBT) Denmark $0.056B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
Omega Therapeutics (OMGA) United States $0.053B 0.00
Celularity (CELU) United States $0.051B 0.00
Kezar Life Sciences (KZR) United States $0.050B 0.00
Estrella Immunopharma (ESLA) United States $0.050B 0.00
Rallybio (RLYB) United States $0.050B 0.00
Exicure (XCUR) United States $0.049B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.047B 0.00
Passage Bio (PASG) United States $0.047B 0.00
AN2 Therapeutics (ANTX) United States $0.046B 0.00
Aileron Therapeutics (ALRN) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
Gelteq (GELS) Australia $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.045B 0.00
Precision BioSciences (DTIL) United States $0.043B 0.00
Elevation Oncology (ELEV) United States $0.043B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Clene (CLNN) United States $0.042B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
OnKure Therapeutics (OKUR) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.040B 0.00
BRIACELL THERAP (BCTX) Canada $0.040B 0.00
Rapt Therapeutics (RAPT) United States $0.038B 0.00
Opus Genetics (IRD) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.038B 0.00
Oncobiologics (OTLK) United States $0.037B 0.00
CalciMedica (CALC) United States $0.036B 0.00
Affimed (AFMD) Germany $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.036B 0.00
SAB Biotherapeutics (SABS) United States $0.036B 0.00
Forte Biosciences (FBRX) United States $0.035B 0.00
Beyond Air (XAIR) United States $0.035B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.035B 0.00
RenovoRx (RNXT) United States $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.033B 0.00
Curis (CRIS) United States $0.032B 0.00
NextCure (NXTC) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
Longeveron (LGVN) United States $0.029B 0.00
KALA BIO (KALA) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
Pluri (PLUR) Israel $0.028B 0.00
HOOKIPA Pharma (HOOK) United States $0.027B 0.00
MiNK Therapeutics (INKT) United States $0.026B 0.00
Senti Biosciences (SNTI) United States $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
LakeShore Biopharma (LSB) China $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
Ocean Biomedical (OCEA) United States $0.023B 0.00
Athira Pharma (ATHA) United States $0.023B 0.00
IN8bio (INAB) United States $0.023B 0.00
GeoVax Labs (GOVX) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
Tenax Therapeutics (TENX) United States $0.020B 0.00
MetaVia (MTVA) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Aprea Therapeutics (APRE) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
BioXcel Therapeutics (BTAI) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Spruce Biosciences (SPRB) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.017B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
HCW Biologics (HCWB) United States $0.015B 0.00
Cara Therapeutics (CARA) United States $0.015B 0.00
Cingulate (CING) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
CervoMed (CRVO) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Aptose Biosciences (APTO) Canada $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Vaccinex (VCNX) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Ensysce Biosciences (ENSC) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
GRI Bio (GRI) United States $0.009B 0.00
Apollomics (APLM) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Evaxion Biotech (EVAX) Denmark $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Palisade Bio (PALI) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00